1993•PubMedRequires access
[Problems found in the isolation of mycelial fungi (Fusarium solani) from blood culture (Bacter NR-860)].
F. Sanz, M Soledad Cuétara, Amalia del Palacio, Colin K. Campbell, L’Aurelle A. Johnson, P Urruzunu, M Pía Roiz
Open publisher page 1 citations
Abstract
BACKGROUND: F. solani fungemia is unusual. Patients at risk are immunosuppressed, have underlying malignancy or severe debilitating diseases. METHODS: We report two cases of F. solani fungemia in two non neutropenic patients who had been treated with wide-spectrum antibiotics an/or systemic corticosteroids, parenteral nutrition and intravenous lines. Bactec NR-860 (Becton-Dickinson) system was used, and growth was detected in aerobic conditions (between 3-7 days of incubation). RESULTS: Removal of the catheters with or without i.v. amphotericin B were used successfully. CONCLUSION: The spectrum of Fusarium sp. fungemia is discussed. Current available antifungal therapy is also reviewed.